Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
-3.24%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$73.5B
AUM Growth
-$7.73B
(-9.5%)
Cap. Flow
-$10.9B
Cap. Flow
% of AUM
-14.85%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
2,580
New
227
Increased
861
Reduced
712
Closed
243
Top Buys
| 1 |
PPL Corp
PPL
|
+$274M |
| 2 |
Boeing
BA
|
+$220M |
| 3 |
Estee Lauder
EL
|
+$219M |
| 4 |
Fidelity National Information Services
FIS
|
+$160M |
| 5 |
Kenvue
KVUE
|
+$151M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$517M |
| 2 |
Union Pacific
UNP
|
+$430M |
| 3 |
Pinnacle West Capital
PNW
|
+$189M |
| 4 |
Wells Fargo
WFC
|
+$189M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| 1 | Technology | 19.75% |
| 2 | Healthcare | 13.74% |
| 3 | Financials | 13.34% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Utz Brands
UTZ
$1.13B
| $19K | ﹤0.01% |
1,450
-351,258
| -100% | -$4.6M |
|
1902
Aecom
ACM
$16.5B
| $18K | ﹤0.01% |
226
-6
| -3% | -$478 |
|
1903
Kaltura
KLTR
$233M
| $18K | ﹤0.01% |
10,707
+1,116
| +12% | +$1.88K |
|
1904
Red Violet
RDVT
$717M
| $18K | ﹤0.01% |
+941
| New | +$18K |
|
1905
Embecta
EMBC
$891M
| $17K | ﹤0.01% |
1,132
-1,327
| -54% | -$19.9K |
|
1906
First Merchants
FRME
$2.32B
| $17K | ﹤0.01% |
647
| – | – |
|
1907
Magna International
MGA
$13B
| $17K | ﹤0.01% |
+321
| New | +$17K |
|
1908
Principal Financial Group
PFG
$17.8B
| $17K | ﹤0.01% |
240
| – | – |
|
|
TGI
1909
DELISTED
Triumph Group
TGI
| $17K | ﹤0.01% |
+2,332
| New | +$17K |
|
1910
TransUnion
TRU
$18.3B
| $17K | ﹤0.01% |
250
| – | – |
|
1911
Allogene Therapeutics
ALLO
$253M
| $17K | ﹤0.01% |
5,749
+250
| +5% | +$739 |
|
1912
Cullen/Frost Bankers
CFR
$8.27B
| $17K | ﹤0.01% |
195
| – | – |
|
1913
Iovance Biotherapeutics
IOVA
$858M
| $16K | ﹤0.01% |
3,681
+146
| +4% | +$635 |
|
1914
Janux Therapeutics
JANX
$1.43B
| $16K | ﹤0.01% |
+1,667
| New | +$16K |
|
1915
Manulife Financial
MFC
$52.4B
| $16K | ﹤0.01% |
921
| – | – |
|
1916
Vir Biotechnology
VIR
$728M
| $16K | ﹤0.01% |
1,799
+542
| +43% | +$4.82K |
|
|
GMDA
1917
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $16K | ﹤0.01% |
16,679
+670
| +4% | +$643 |
|
1918
Adverum Biotechnologies
ADVM
$72.8M
| $15K | ﹤0.01% |
1,049
+43
| +4% | +$615 |
|
1919
Axalta
AXTA
$6.8B
| $15K | ﹤0.01% |
576
| – | – |
|
1920
Nathan's Famous
NATH
$431M
| $15K | ﹤0.01% |
213
| – | – |
|
1921
Prime Medicine
PRME
$734M
| $15K | ﹤0.01% |
1,670
+66
| +4% | +$593 |
|
1922
Red Robin
RRGB
$110M
| $15K | ﹤0.01% |
1,949
| – | – |
|
1923
Fresenius Medical Care
FMS
$14.8B
| $14K | ﹤0.01% |
+671
| New | +$14K |
|
1924
Roku
ROKU
$14.3B
| $14K | ﹤0.01% |
200
+188
| +1,567% | +$13.2K |
|
|
SGEN
1925
DELISTED
Seagen Inc. Common Stock
SGEN
| $14K | ﹤0.01% |
69
+56
| +431% | +$11.4K |
|